Literature DB >> 3330530

New aspects of clinical drug resistance: the role of gene amplification and the reversal of resistance in drug refractory cancer.

R F Ozols, K Cowan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3330530

Source DB:  PubMed          Journal:  Important Adv Oncol        ISSN： 0883-5896


× No keyword cloud information.
  9 in total

1.  Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.

Authors:  A W Himmelmann; S Danhauser-Riedl; G Steinhauser; R Busch; E J Modest; A Noseda; J Rastetter; W R Vogler; W E Berdel
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.

Authors:  Y J Lidor; K C O'Briant; F J Xu; T C Hamilton; R F Ozols; R C Bast
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

3.  Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.

Authors:  D Fan; G Poste; C Seid; L E Earnest; T Bull; R K Clyne; I J Fidler
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 4.  Mechanisms of cellular resistance to cisplatin.

Authors:  G A Hospers; N H Mulder; E G De Vries
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

5.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.

Authors:  L S Borman; W G Bornmann; M E Kuehne
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.

Authors:  S D Harrison; R W Brockman; M W Trader; W R Laster; D P Griswold
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850

8.  Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.

Authors:  I M Pannacciulli; R A Lerza; G V Bogliolo; M P Mencoboni; A G Saviane
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

9.  A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

Authors:  J Verweij; H Herweijer; R Oosterom; M E van der Burg; A S Planting; C Seynaeve; G Stoter; K Nooter
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.